Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/03/2010US20100137241 Imidated biopolymer adhesive and hydrogel
06/03/2010US20100137240 Use of nucleoside derivatives as anti-koi herpes virus in fish
06/03/2010US20100137239 Gemcitabine combination therapy
06/03/2010US20100137238 Method For Increasing Hair Growth
06/03/2010US20100137237 Process for the preparation of an (rp)-8-substituted camps
06/03/2010US20100137236 Compositions Comprising a GPR109 Ligand For Treating Disorders of the Digestive Tract and/or Cancer
06/03/2010US20100137235 Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics
06/03/2010US20100137234 10-substituted macrolide antibiotics
06/03/2010US20100137232 Composition comprising a diuretic and a cardiac glycoside for the treatment of dna viral infections of the eye
06/03/2010US20100137231 6"-amino-6"-deoxygalactosylceramides
06/03/2010US20100137230 New pyridin-2-one compounds
06/03/2010US20100137229 Method Of Enhancing Lysosomal Alpha-Galactosidase A
06/03/2010US20100137228 Drugs, foods or drinks with the use of algae-derived physiologically active substances
06/03/2010US20100137215 Novel tetrahydro-1h-pyrido[4,3-b]indoles
06/03/2010US20100137211 Methods and compositions for intra-articular coagulation proteins
06/03/2010US20100137208 Intratumorally administered lactoferrin in the treatment of malignantneoplasms and other hyperproliferative diseases
06/03/2010US20100137206 Novel ligand guided block copolymers for targeted drug delivery
06/03/2010US20100137205 Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
06/03/2010US20100137198 Pharmaceutical composition for topical application
06/03/2010US20100137196 Histone deacetylases, and uses related thereto
06/03/2010US20100137194 Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism
06/03/2010US20100137193 Chitosan derivatives to treat animals or optimize animal health
06/03/2010US20100137192 Compositions and methods for treating or ameliorating mycobacterial infections
06/03/2010US20100136695 Double-stranded oligonucleotides
06/03/2010US20100136623 Mutations in ion channels
06/03/2010US20100136581 Diagnosis and treatment of malignant neoplasms
06/03/2010US20100136577 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
06/03/2010US20100136146 Composition for heart disease, its active ingredients, method to prepare same and uses thereof
06/03/2010US20100136145 Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity
06/03/2010US20100136144 Composition containing a quinoa extract for dermatological use
06/03/2010US20100136143 New compositions and methods for cell killing
06/03/2010US20100136142 Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
06/03/2010US20100136141 Hemostatic agent
06/03/2010US20100136139 Cancer marker and therapeutic agent for cancer
06/03/2010US20100136138 Treatment of lung cancer
06/03/2010US20100136137 Therapeutic combination of a panher/vegfr2 kinase inhibitor and a platinum compound
06/03/2010US20100136136 JAK-2 Modulators and Methods of Use
06/03/2010US20100136135 Method of Selecting Phosphate Binder and its Uses Thereof
06/03/2010US20100136133 Nutritive compositions and methods of using same
06/03/2010US20100136129 Nanoparticles comprising a cyclodextrin and a biologically active molecule and uses thereof
06/03/2010US20100136127 Solid preparation comprising alogliptin and metformin hydrochloride
06/03/2010US20100136125 Method of treating inflammatory bowel disease
06/03/2010US20100136124 Nanoparticle-coated capsule formulation for dermal drug delivery
06/03/2010US20100136122 Oral Preparation Comprising Pioglitazone
06/03/2010US20100136121 Medicaments
06/03/2010US20100136120 Compositions and methods for forming and strengthening bone
06/03/2010US20100136119 Controlled-release preparation containing cilostazol and process for the preparation thereof
06/03/2010US20100136116 Novel hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form b
06/03/2010US20100136115 Pharmaceutical Titanium Dioxide Composite Allowing Disappearance of Drug Efficacy By Light Irradiation
06/03/2010US20100136111 Pharmaceutical compositions of diclofenac and misoprostol
06/03/2010US20100136109 Sustained release
06/03/2010US20100136108 Formulation for retinoid-containing soft gelatin capsules
06/03/2010US20100136107 Liquid Therapeutic Composition
06/03/2010US20100136106 Modified Release Famciclovir Compositions
06/03/2010US20100136105 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
06/03/2010US20100136101 Compositions and methods for sirna inhibition of hif-1 alpha
06/03/2010US20100136100 Removal promoters and inhibitor for apoptosis cells in vivo
06/03/2010US20100136097 Systems for modulating inflammation
06/03/2010US20100136096 Systems for modulating inflammation
06/03/2010US20100136095 Systems for modulating inflammation
06/03/2010US20100136094 Systems for modulating inflammation
06/03/2010US20100136092 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same
06/03/2010US20100136090 Helically-Shaped Drug Delivery System
06/03/2010US20100136089 Location of fatty acid esters on tampons and toxin inhibiting efficacy
06/03/2010US20100136087 Composition for Promoting Cartilage Formation or Repair Comprising a NELL Gene Product and Method of Treating Cartilage-Related Conditions Using Such Composition
06/03/2010US20100136080 Material depot for releasing an antibacterial active agent
06/03/2010US20100136072 Polymeric Coatings that Inactivate Viruses and Bacteria
06/03/2010US20100136057 Virulence of streptococci
06/03/2010US20100136056 Novel insertion sites in pox vectors
06/03/2010US20100136054 Flavivirus ns1 subunit vaccine
06/03/2010US20100136046 Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
06/03/2010US20100136039 Borrelia antigens
06/03/2010US20100136035 Method for modulating atherosclerosis
06/03/2010US20100136032 Trimeric ox40-immunoglobulin fusion protein and methods of use
06/03/2010US20100136031 Anti-cxcr1 compositions and methods
06/03/2010US20100136029 Use of Tri-Substituted Glycerol Compounds for the Treatment of Hematological Malignancies
06/03/2010US20100136026 Ship Inhibition to Direct Hematopoietic Stem Cells and Induce Extramedullary Hematopoiesis
06/03/2010US20100136024 Selective Inhibition of Histone Deacetylase 6 for Ocular Neuroprotection or for Treatment or Control of Glaucoma
06/03/2010US20100136017 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer
06/03/2010US20100136015 Methods and compositions for regulating iron homeostasis by modulation of bmp-6
06/03/2010US20100136012 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions
06/03/2010US20100136010 Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
06/03/2010US20100136004 Compositions and methods for treating neurological disorders
06/03/2010US20100136002 Methods for treating and preventing multiple sclerosis
06/03/2010US20100136001 Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
06/03/2010US20100135999 Quinoline-carboxamide derivatives as p2y12 antagonists
06/03/2010US20100135996 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type ii receptor (amhr-ii)
06/03/2010US20100135995 Methods of modulating angiogenesis
06/03/2010US20100135993 Method of treating malignant mesothelioma
06/03/2010US20100135990 Modulation of NR2F6 and methods and uses thereof
06/03/2010US20100135988 Methods for identifying agents for preventing or treating proliferative diseases, and for inhibiting extracellular matrix or alpha1 type IV collagen
06/03/2010US20100135985 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them an uses thereof
06/03/2010US20100135984 Anti-inflammatory compositions and methods
06/03/2010US20100135983 Anti-inflammatory compositions and methods
06/03/2010US20100135982 Simethicone solid oral dosage form
06/03/2010US20100135981 Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases
06/03/2010US20100135977 Compositions and methods for treating metabolic diseases
06/03/2010US20100135975 CD133 Epitopes
06/03/2010US20100135968 Oligodendrocyte Production From Multipotent Neural Stem Cells
06/03/2010US20100135966 Agents for treating flaviviridae infections
1 ... 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 2258 2259 2260 2261 ... 7860